SLN
Silence Therapeutics PLC
10.60$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -25.0% | +647.9% | -96.2% | +91.0% | +2,030.3% | -99.2% | +67.2% | -48.2% | -78.6% | +1,139.1% | -100.0% | – | |
| – | -16.2% | +108.0% | -5.8% | +5.2% | -42.1% | -95.7% | +66.9% | -45.1% | -81.3% | +873.4% | -7.4% | – | |
| – | -36.8% | +1,613.0% | -115.8% | – | – | -99.5% | +67.4% | -50.2% | -76.8% | +1,284.0% | -135.5% | – | |
| – | +11.2% | +19.2% | -7.2% | +39.2% | +33.3% | +32.0% | -10.1% | -15.1% | -57.4% | -4.6% | -0.4% | – | |
| – | -17.0% | +61.2% | -20.3% | +5.9% | -3.7% | +84.3% | -29.2% | -17.6% | -35.6% | +88.2% | -33.2% | – | |
| – | +1.2% | +31.5% | -11.9% | +28.4% | +23.4% | +42.9% | -10.3% | -20.3% | -52.6% | +22.8% | -15.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11,500.0% | -98.6% | +1,307.7% | +4,600.5% | +34.2% | +0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -255.5% | – | – | – | – | – | – | |
| – | – | – | -870.1% | – | – | +0.0% | -99.9% | -92.7% | -200.0% | – | – | – | |
| – | – | – | – | – | – | -360.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -610.7% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.